These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 21690207)

  • 21. Effects of long-term strontium ranelate treatment on the risk of nonvertebral and vertebral fractures in postmenopausal osteoporosis: Results of a five-year, randomized, placebo-controlled trial.
    Reginster JY; Felsenberg D; Boonen S; Diez-Perez A; Rizzoli R; Brandi ML; Spector TD; Brixen K; Goemaere S; Cormier C; Balogh A; Delmas PD; Meunier PJ
    Arthritis Rheum; 2008 Jun; 58(6):1687-95. PubMed ID: 18512789
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of prior bisphosphonate therapy on the subsequent BMD and bone turnover response to strontium ranelate.
    Middleton ET; Steel SA; Aye M; Doherty SM
    J Bone Miner Res; 2010 Mar; 25(3):455-62. PubMed ID: 20201000
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term treatment of postmenopausal osteoporosis with strontium ranelate: results at 8 years.
    Reginster JY; Bruyère O; Sawicki A; Roces-Varela A; Fardellone P; Roberts A; Devogelaer JP
    Bone; 2009 Dec; 45(6):1059-64. PubMed ID: 19679207
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Continuous broad protection against osteoporotic fractures with strontium ranelate.
    Ferrari S
    Rheumatology (Oxford); 2009 Oct; 48 Suppl 4():iv20-4. PubMed ID: 19783590
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Strontium ranelate--new paradigm in the treatment of postmenopausal osteoporosis].
    Korsić M; Giljević Z; Kastelan D
    Lijec Vjesn; 2006; 128(5-6):180-2. PubMed ID: 16910420
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Strontium ranelate decreases plasma homocysteine levels in postmenopausal osteoporotic women.
    Bayhan I; Uygur D; Ugurlu N; Ozaksit G
    Rheumatol Int; 2009 Jan; 29(3):263-6. PubMed ID: 18818926
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Osteoporosis: from early fracture prevention to better bone health with strontium ranelate.
    Cortet B
    Rheumatology (Oxford); 2009 Oct; 48 Suppl 4():iv14-9. PubMed ID: 19783589
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Strontium does not affect the intrinsic bone quality at tissue and BSU levels in iliac samples from Macaca fascicularis monkeys.
    Doublier A; Farlay D; Bala Y; Boivin G
    Bone; 2014 Jul; 64():18-24. PubMed ID: 24662618
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bone histomorphometry of transiliac paired bone biopsies after 6 or 12 months of treatment with oral strontium ranelate in 387 osteoporotic women: randomized comparison to alendronate.
    Chavassieux P; Meunier PJ; Roux JP; Portero-Muzy N; Pierre M; Chapurlat R
    J Bone Miner Res; 2014 Mar; 29(3):618-28. PubMed ID: 23959630
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Improvement in bone strength parameters. The role of strontium ranelate.
    Tournis S
    J Musculoskelet Neuronal Interact; 2007; 7(3):266-7. PubMed ID: 17947810
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of strontium ranelate on lumbar spine bone mineral density in women with established osteoporosis previously treated with teriparatide.
    Anastasilakis AD; Polyzos SA; Avramidis A; Papatheodorou A; Terpos E
    Horm Metab Res; 2009 Jul; 41(7):559-62. PubMed ID: 19204890
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of 3- and 5-year treatment with risedronate on bone mineralization density distribution in triple biopsies of the iliac crest in postmenopausal women.
    Zoehrer R; Roschger P; Paschalis EP; Hofstaetter JG; Durchschlag E; Fratzl P; Phipps R; Klaushofer K
    J Bone Miner Res; 2006 Jul; 21(7):1106-12. PubMed ID: 16813531
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Strontium ranelate treatment improves oxidative damage in osteoporotic rat model.
    Yalin S; Sagír O; Comelekoglu U; Berköz M; Eroglu P
    Pharmacol Rep; 2012; 64(2):396-402. PubMed ID: 22661191
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Protelos: nonvertebral and hip antifracture efficacy in postmenopausal osteoporosis.
    Adami S
    Bone; 2006 Feb; 38(2 Suppl 1):23-7. PubMed ID: 16434247
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy and safety of strontium ranelate in the treatment of osteoporosis in men.
    Kaufman JM; Audran M; Bianchi G; Braga V; Diaz-Curiel M; Francis RM; Goemaere S; Josse R; Palacios S; Ringe JD; Felsenberg D; Boonen S
    J Clin Endocrinol Metab; 2013 Feb; 98(2):592-601. PubMed ID: 23341486
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of strontium ranelate on serum leptin and bone turnover markers in women with established postmenopausal osteoporosis.
    Bayhan I; Dogan NU; Ozaksit G; Uygur D; Ugurlu N; Ugur M
    J Reprod Med; 2013; 58(7-8):319-23. PubMed ID: 23947082
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Strontium ranelate for osteoporosis?
    Drug Ther Bull; 2006 Apr; 44(4):29-32. PubMed ID: 16617933
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Strontium ranelate in the prevention of osteoporotic fractures.
    Reginster JY; Malaise O; Neuprez A; Bruyere O
    Int J Clin Pract; 2007 Feb; 61(2):324-8. PubMed ID: 17263720
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effects of strontium ranelate in Asian women with postmenopausal osteoporosis.
    Hwang JS; Chen JF; Yang TS; Wu DJ; Tsai KS; Ho C; Wu CH; Su SL; Wang CJ; Tu ST
    Calcif Tissue Int; 2008 Nov; 83(5):308-14. PubMed ID: 18843436
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Strontium is incorporated in different levels into bones and teeth of rats treated with strontium ranelate.
    Oliveira JP; Querido W; Caldas RJ; Campos AP; Abraçado LG; Farina M
    Calcif Tissue Int; 2012 Sep; 91(3):186-95. PubMed ID: 22806682
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.